Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Signal pathways of melanoma and targeted therapy
W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
[HTML][HTML] DNA methyltransferases in cancer: biology, paradox, aberrations, and targeted therapy
J Zhang, C Yang, C Wu, W Cui, L Wang - Cancers, 2020 - mdpi.com
DNA methyltransferases are an essential class of modifiers in epigenetics. In mammals,
DNMT1, DNMT3A and DNMT3B participate in DNA methylation to regulate normal …
DNMT1, DNMT3A and DNMT3B participate in DNA methylation to regulate normal …
[HTML][HTML] The current state of treatment and future directions in cutaneous malignant melanoma
Malignant melanoma is the leading cause of death among cutaneous malignancies. While
its incidence is increasing, the most recent cancer statistics show a small but clear decrease …
its incidence is increasing, the most recent cancer statistics show a small but clear decrease …
NFE2L2 is a potential prognostic biomarker and is correlated with immune infiltration in brain lower grade glioma: a pan‐cancer analysis
Q Ju, X Li, H Zhang, S Yan, Y Li… - Oxidative Medicine and …, 2020 - Wiley Online Library
Nuclear factor, erythroid 2 like 2 (NFE2L2, NRF2) is a transcription factor that regulates
various antioxidant enzymes. It plays a vital physiological role in regulating oxidative stress …
various antioxidant enzymes. It plays a vital physiological role in regulating oxidative stress …
[HTML][HTML] EZH2, a prominent orchestrator of genetic and epigenetic regulation of solid tumor microenvironment and immunotherapy
S Sun, F Yu, D Xu, H Zheng, M Li - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Immune checkpoint blockade (ICB) is regarded as a promising strategy for cancer therapy.
The histone methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), has been implicated …
The histone methyltransferase, Enhancer of Zeste Homolog 2 (EZH2), has been implicated …
Attenuation of SARS‐CoV‐2 replication and associated inflammation by concomitant targeting of viral and host cap 2'‐O‐ribose methyltransferases
The SARS‐CoV‐2 infection cycle is a multistage process that relies on functional
interactions between the host and the pathogen. Here, we repurposed antiviral drugs …
interactions between the host and the pathogen. Here, we repurposed antiviral drugs …
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
S Chen, Y Zhao, S Liu, J Zhang, YG Assaraf… - Drug Resistance …, 2022 - Elsevier
Despite the rapid advancement in the introduction of new drugs for cancer therapy, the
frequent emergence of drug resistance leads to disease progression or tumor recurrence …
frequent emergence of drug resistance leads to disease progression or tumor recurrence …
EZH2: an accomplice of gastric cancer
W Yu, N Liu, X Song, L Chen, M Wang, G **ao, T Li… - Cancers, 2023 - mdpi.com
Simple Summary Enhancer of zeste homolog 2 (EZH2) modifies the trimethylation of Lys-27
of histone 3, affecting downstream target genes' expression. It was reported that EZH2 is …
of histone 3, affecting downstream target genes' expression. It was reported that EZH2 is …
Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3/ALOX15 axis
D Wang, F Wang, H Zhang, P Chen, M Yang - Cancer Science, 2023 - Wiley Online Library
Acute myeloid leukemia (AML) is a major leukemia with high mortality. Ferroptosis is an
important regulator of cancers. However, the role of ferroptosis and its regulatory …
important regulator of cancers. However, the role of ferroptosis and its regulatory …
Epigenetic basis and targeting of cancer metastasis
Despite the development of novel therapeutic approaches and improved clinical
management, survival from metastatic disease remains poor. Indeed, metastasis accounts …
management, survival from metastatic disease remains poor. Indeed, metastasis accounts …